Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Orléans – page 9

149 clinical trials in Orléans, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Orléans at a glance
149
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

149 trials in Orléans

Open in trial search

Rheumatoid arthritis

Not recruiting

Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Centre Hospitalier Universitaire D Orleans

Sepsis+1

Not recruiting

Study of REGN7544 for Treating Adults with Low Blood Pressure Caused by Sepsis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:REGN7544
  • Sponsor:Regeneron Pharmaceuticals Inc.

Non-small cell lung cancer stage IV

Not recruiting

Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Plasma cell myeloma

Not recruiting

Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Daratumumab
  • Sponsor:Centre Hospitalier Universitaire De Lille

Sjogren's syndrome

Not recruiting

Study on the Effects of Abiprubart for Patients with Sjögren’s Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:KPL-404
  • Sponsor:Kiniksa Pharmaceuticals GmbH

Respiratory failure

Not recruiting

Study on the Effects of Methylprednisolone and Isavuconazonium Sulfate in Immunocompromised Patients with Acute Respiratory Failure of Unknown Cause

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Assistance Publique Hopitaux De Paris

Chronic myeloid leukaemia

Not recruiting

Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Centre Hospitalier De Versailles

Study Comparing Abatacept and Tocilizumab for Adults with Rheumatoid Arthritis Not Responding to Previous Treatments

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Groupement Des Hopitaux De L'Institut Catholique De Lille

Acute myeloid leukaemia

Not recruiting

Study on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Centre Antoine Lacassagne

Peripheral T-cell lymphoma unspecified

Not recruiting

Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:LYSARC

General physical health deterioration+1

Not recruiting

Study on Durvalumab for Patients with Poor General Condition and Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Lymphatic malformation

Not recruiting

Study on the Effects of Topical Sirolimus for Lingual Microcystic Lymphatic Malformations in Children and Adults

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Sirolimus
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Orléans

What the registry says about research in the country

01 Rheumatology Research

Innovative studies focusing on autoimmune conditions including trials evaluating new treatments for psoriatic and rheumatoid arthritis. Research includes assessment of maintenance therapies and novel drug combinations.

  • Psoriatic Arthritis Treatment
  • Rheumatoid Arthritis Management
  • Sjögren's Disease Therapies

Particular emphasis on evaluating long-term treatment efficacy and bone erosion prevention.

02 Oncology Studies

Comprehensive research in hematologic malignancies and solid tumors, with significant focus on multiple myeloma and breast cancer treatment innovations.

  • Multiple Myeloma Therapies
  • Triple Negative Breast Cancer
  • Pancreatic Adenocarcinoma

Advanced treatment protocols combining immunotherapy with traditional approaches.

03 Infectious Disease Research

Cutting-edge studies in HIV treatment and viral infections, exploring new therapeutic approaches and treatment optimization strategies.

  • HIV-1 Treatment Innovations
  • Viral Lung Infections
  • Immunotherapy Applications

Focus on developing long-acting treatments and improving patient outcomes.

Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.